Wireless-enabled blood glucose meter developer Telcare has raised $2.5 million of a targeted $4 million equity offering, according to a regulatory filing. Telcare plans to offer its blood glucose meter offering (pending FDA clearance) to its customers at the same pricepoint of "disconnected" devices that are already on the market.
According to the company: "[The] Telcare blood glucose meter...
